Compare the measured products in ecdysterone studies, including batch differences and reporting limits, before applying a result to a supplement.
A supplement label and a measured ingredient amount are different things. When comparing ecdysterone studies, check the tested product and batch before comparing the advertised dose. The examples below keep the product measurement separate from the claimed benefit.
This is a guide to interpreting research, not a dose recommendation or a product test.
The ten-week Isenmann study used Peak Ecdysone, labeled as containing 100 mg ecdysterone plus 100 mg leucine per capsule. Chemical analysis found 6 mg ecdysterone per capsule. The two training groups therefore received measured amounts of 12 or 48 mg daily, rather than the label-derived 200 or 800 mg.
Forty-six men completed the study across four groups, matched on performance and body composition. The report describes larger bench-press improvements in the supplemented training groups and a larger muscle-mass increase in the higher-amount group than with placebo. Muscle mass was estimated using bioelectrical impedance, not directly weighed muscle tissue. WADA funded the work.
These findings concern that product, population and training program. They do not establish an optimal dose or validate a different capsule. A summary calling this simply an “800 mg ecdysterone trial” misses the measured exposure.
In the twelve-week Dissemond trial, 24 of 28 enrolled resistance-trained men completed training with a commercial ecdysterone–diosgenin blend or placebo. Improvements occurred over time, without a significant advantage for the supplement.
Testing after the intervention found less than 10 micrograms of ecdysterone per capsule, despite a 25 mg label claim. An older batch of the same product had substantially more. Six capsules from each batch were pooled for analysis; this does not reveal each capsule's content.
The report also contains an unresolved diosgenin discrepancy: its results section gives 15.6 mg per capsule and 31.2% of the label claim, while the abstract gives 10.4%. Do not silently choose a percentage and present the paper as internally consistent.
The negative human result concerns the tested blend. It cannot settle whether the intended amounts would work. The older batch's activity in mouse-derived muscle cells does not establish human benefit.
A March 2026 analytical study examined 13 online-purchased supplements using liquid chromatography–mass spectrometry, which separates and measures specified compounds. Methods describe three individual capsules or tablets per product, with repeated analytical preparations.
Some ecdysterone results were near their declarations; others were substantially lower. Products also contained different proportions of ecdysterone and turkesterone, which the method measured separately.
This is evidence about sampled products, not an estimate of how often every brand or market is mislabeled. Three units and repeated measurements are not three independent manufacturing batches. The study did not measure strength, muscle growth or clinical safety.
Use two columns when reviewing a manufacturer's study citation:
| Product question | Research question |
|---|---|
| What exact ingredient was measured? | Was that ingredient the intervention, or part of a blend? |
| Does the report identify the supplied batch? | Was the study batch tested, or an older one? |
| Are amounts given per capsule, serving or extract? | Were outcomes compared with an appropriate control? |
| Were individual units tested or pooled? | Were outcomes measured in people, cells or animals? |
A favorable answer in one column does not complete the other. If the only available information is a label or an old report, record the current amount as unverified. Do not compensate for suspected underfilling by taking more.
Operation Supplement Safety's June 2026 review describes inconsistent small human studies and uncertain safety for ecdysterone and turkesterone dietary supplements. It distinguishes supplement products from pharmaceutical-grade BIO101 research. Findings for that investigational formulation should not become blanket reassurance about retail extracts.
For a reusable study-reading worksheet, see how to check human evidence. For analytical-document questions, the certificate-of-analysis guide explains identity, quantity and purity as separate measurements; its examples concern peptide materials, not an ecdysterone certification standard.
Powered by BTST